Estrobolome disparities may lead to developing biomarkers that could mitigate cancer risk
Investigating disparities in the composition of the estrobolome, the gut bacterial genes capable of metabolizing estrogens in both healthy individuals and in women diagnosed with estrogen-driven breast cancer may lead to ...
Apr 22, 2016